neuroplasticity < neuroprotection < neuroprotective

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[20-40] [0 - 20][0 - 28]

Ident.	Authors (with country if any)	Title
001497 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
001A01 (2009)	Robert A. Hauser [États-Unis] ; Kelly E. Lyons [États-Unis] ; Terry Mcclain [États-Unis] ; Summer Carter [États-Unis] ; David Perlmutter [États-Unis]	Randomized, double‐blind, pilot evaluation of intravenous glutathione in Parkinson's disease
001C23 (2011)	Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew J. Lees [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni]	The effect of drug treatment on neurogenesis in Parkinson's disease
002051 (2008)	Ilana Schlesinger [Israël] ; Naomi Schlesinger [États-Unis]	Uric acid in Parkinson's disease
002993 (2008)	Anthony H. V. Schapira [Royaume-Uni]	The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease
002C80 (2010)	Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande]	A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease
002D82 (2007)	Anna L. Bartels [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]	Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]‐PK11195 PET
002E01 (2001)	Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France]	Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i -k "neuroprotection" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i  \
                -Sk "neuroprotection" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    neuroprotection
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024